NOTICE – The Fonds de recherche du Québec (FRQ) was established on June 1, 2024, in accordance with the Act to amend the Act respecting the Ministère de l’Économie et de l’Innovation with respect to research. The Fonds de recherche du Québec – Nature et technologies (FRQNT), the Fonds de recherche du Québec – Santé (FRQS) and the Fonds de recherche du Québec – Société et culture (FRQSC) have since been regrouped into the new FRQ, which continues their existence. The rights and obligations of the FRQNT, FRQS and FRQSC have become those of the FRQ; activities continue as usual.

Please note that if you come across an old name or logo of one of the Fonds de recherche du Québec in the program rules or on the website, it should now read as follows:

  • The FRQNT becomes the Nature et technologies sector;
  • The FRQS becomes the Santé sector;
  • The FRQSC becomes the Société et culture sector.

Thank you for your understanding.

Back to stories & reports

Mathilde Mouchiroud

PhD student at the Quebec Heart and Lung Institute Research Centre
Université Laval

Award-winning publication: The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis

Published in: JCI Insight
 

Abstract

Obesity has become a global epidemic, especially since it is linked to a number of pathologies including type 2 diabetes, insulin resistance, dyslipidemia and cardiovascular disease. In addition, persons who are obese suffer from a pathology known as non-alcoholic fatty liver disease (NAFLD), which is associated with several complications such as dyslipidemia and atherosclerosis. The mechanisms by which NAFLD bring about atherogenic dyslipidemia leading to heart disease remain unknown. However, the data gathered by Mathilde Mouchiroud identify the hepatokine Tsukushi as a new possible link between hepatic metabolism dysfunction, cholesterol metabolism disturbance and the development of cardiovascular disease—one of the leading causes of death among obese patients.